-
1
Progress Update on STING Agonists as Vaccine Adjuvants
Published 2025-03-01Subjects: Get full text
Article -
2
Potential therapeutic strategies for colitis and colon cancer: bidirectional targeting STING pathway
Published 2025-01-01Subjects: Get full text
Article -
3
STING Agonists and How to Reach Their Full Potential in Cancer Immunotherapy
Published 2025-05-01Subjects: Get full text
Article -
4
Exploring the synergy between tumor microenvironment modulation and STING agonists in cancer immunotherapy
Published 2024-12-01Subjects: Get full text
Article -
5
-
6
Fluorinated small molecule derivatives in cancer immunotherapy: emerging frontiers and therapeutic potential
Published 2025-07-01Subjects: Get full text
Article -
7
Synergistic chemo-immunotherapy for osteosarcoma via a pH-responsive multi-component nanoparticle system
Published 2025-04-01Subjects: Get full text
Article -
8
-
9
A Purely Biomanufactured System for Delivering Nanoparticles and STING Agonists
Published 2025-01-01Subjects: Get full text
Article -
10
-
11
-
12
-
13
Enhancing tumor immunotherapy with smart nanoparticles for reprogramming macrophages and blocking the CD47/Sirpα pathway
Published 2025-06-01Subjects: Get full text
Article -
14
Enhanced antitumor efficacy of STING agonist MSA-2 by lipid nanoparticles delivering circular IL-23 mRNA and platinum-modified MSA-2 combination
Published 2025-02-01Subjects: “…STING agonist…”
Get full text
Article -
15